Cargando…
Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
Tumour-derived p53 mutants are thought to have acquired ‘gain-of-function’ properties that contribute to oncogenicity. We have tested the hypothesis that p53 mutants suppress p53-target gene expression, leading to enhanced cellular growth. Silencing of mutant p53 expression in several human cell lin...
Autores principales: | Vikhanskaya, Faina, Lee, Ming Kei, Mazzoletti, Marco, Broggini, Massimo, Sabapathy, Kanaga |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874625/ https://www.ncbi.nlm.nih.gov/pubmed/17344317 http://dx.doi.org/10.1093/nar/gkm099 |
Ejemplares similares
-
The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2015) -
Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2021) -
Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019) -
Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023) -
Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019)